{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04687",
    "Peptide Name": "(I5,R8) Mastoparan ([I5,R8] MP, Mastoparan-L analog, Synthetic AMPs, Leu-rich, XXA, UCLL1c)",
    "Source": "designed, amino acid substitution, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "INLKILARLAKKIL",
    "Sequence Length": 14,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antiviral",
      "Antifungal",
      "candidacidal"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 5,
    "Boman Index": 0.01,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "64%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (85.71%) toMastoparan-LL: 29%, I=K: 21%, A: 14%.Activity: Active against Gram- E. coli ATCC 25922 (MIC 12.5 uM), P. aeruginosa ATCC 27853 (MIC 6.25 uM), K. pneumoniae ATCC 13883 (MIC 6.25 uM), A. baumannii ATCC 19606 (MIC 3 uM), Gram+ S. aureus ATCC 25923 (MIC 25 uM), S. pyogenes ATCC 19615 (MIC 6.25 uM), L. ivanovii Li 4pVS2 (MIC 50 uM), E.faecalis ATCC 29212 (MIC >100 uM),fungi C. albicans ATCC 90028 (MIC 12.5 uM), and C. parapsilosis ATCC 22019 (MIC 25 uM).Virus: Inhibited entry of Human alphaherpesvirus 1 (HSV-1) (EC50 6.22 uM).In vitro toxicity: rat RBC: HC50 > 200 uM, poor hemo.lytic. THP-1-derived macrophages (IC50 24..5 uM0, and HEK-293 (IC50 > 200 uM).MOA:bacteria:E. coli: MOA:bacteria:S. aureus: membrane permeation and depolarization.SAR: C-terminal amidation increased peptide activity.",
    "Author": "Irazazabal LN, Porto WF, Ribeiro SM, Casale S, Humblot V, Ladram A, Franco OL. 2016",
    "Reference": "Biochim Biophys Acta. 2016 Nov;1858(11):2699-2708. doi: 10.1016/j.bbamem.2016.07.001.PubMed",
    "Title": "Selective amino acid substitution reduces cytotoxicity of the antimicrobial peptide mastoparan."
  },
  "3D Structure": []
}